AtaiBeckley Inc. ATAI 深 沪
等待开盘 10-06 09:30:00 美东时间
7.35
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 7.35
- 总市值 27.26亿
- 52周最高 7.45
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.265
- 委 比 0.00%
- 总股本 3.71亿
- 历史最高 22.91
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.025
- 每 手 1
- 风险率 1.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多今年已豪掷超200亿美元！礼来CEO：将瞄准制药“空白领域”，继续寻求更大规模并购
礼来首席执行官戴夫·里克表示，投资者可以预期，礼来公司将推进规模更大的交易，因为该公司正在科学界的“空白领域”广泛搜寻资产。
09-29 13:44
今年已豪掷超200亿美元！礼来(LLY.US)CEO：将瞄准制药“空白领域”，继续寻求更大规模并购
礼来(LLY.US)首席执行官戴夫·里克斯(Dave Ricks)表示，投资者可以预期，礼来公司将推进规模更大的交易，类似其以78亿美元收购Centessa ...
09-29 08:56
Cantor Fitzgerald Suspends Neutral Rating on AtaiBeckley Inc
Cantor Fitzgerald suspends Neutral rating on AtaiBeckley Inc (NASDAQ:ATAI).
09-22 18:55
Deal Dispatch: Bending Spoons Acquires Miro For $1.35B, Kinetik Up For Sale, LIV Golf Bankruptcy
New On The Block Kinetik Holdings Inc (NYSE:KNTK), the Blackstone-backed Delaware Basin pipeline operator, is weighing strategic alternatives, including a potential sale, Bloomberg reports. Read Also: Apptronik’s Private Market Share Soars 3,600% on Humanoid Robot Hype Updates From The Block Labcorp...
09-12 01:10
AtaiBeckley Says Hart-Scott-Rodino Waiting Period For Merger With Eli Lilly Expired On Aug 28, 2026; UK Competition Authority Has No Further Questions On Merger As Of August 21, 2026
As previously disclosed, AtaiBeckley Inc. (the "Company") entered into an Agreement and Plan of Merger, dated as of July 15, 2026 (the "Merger Agreement"), with Eli Lilly and Company, an Indiana corporation ("Parent") and Albali Acquisition Corporation, a Delaware corporation and indirect wholly own...
09-01 04:42
美股大行评级 | 业绩大超预期！ CoreWeave、超微电脑、Lumentum绩后获多家大行上调目标价
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从49美元升至56美元；韦德布什：维持Zura Bio"跑赢大市"评级，目标价从15美元升至22美元
08-13 11:44
CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. HC Wainwright & Co. raised the price target for Belite Bio Inc (NASDAQ:BLTE) from $200 to $214. HC Wainwright ...
08-12 19:53
Deutsche Bank Downgrades AtaiBeckley to Hold, Lowers Price Target to $8
Deutsche Bank analyst David Hoang downgrades AtaiBeckley (NASDAQ:ATAI) from Buy to Hold and lowers the price target from $12 to $8.
08-12 17:57
礼来凭爆款药物上调业绩目标 击退“减肥药降温”质疑
礼来在最新的财报中上调了2026年销售指引，公司的减重药业务在第二季度表现远超预期，缓解了投资者对于“减肥药热潮正在降温”的担忧。 礼来周三表示，公司预计20...
08-05 23:48
